Process View
The multiplication or reproduction of smooth muscle cells, resulting in the expansion of a cell population.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "smooth muscle cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 1.000 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.997 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.961 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.942 | Human Rat | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.921 | ||
| EGFR | epidermal growth factor receptor | 0.898 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.891 | Rat | |
| JAG1 | jagged 1 | 0.852 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.842 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.834 | Human | |
| C1QA | complement component 1, q subcomponent, A chain | 0.805 | Human | |
| NCOR2 | nuclear receptor corepressor 2 | 0.754 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.709 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.675 | ||
| PSEN1 | presenilin 1 | 0.645 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.569 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.480 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.460 | Human | |
| IRS1 | insulin receptor substrate 1 | 0.442 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.428 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.402 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.402 | Rat | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.393 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.355 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.351 | Rat | |
| NCOR1 | nuclear receptor corepressor 1 | 0.346 | ||
| JUNB | jun B proto-oncogene | 0.340 | ||
| S100B | S100 calcium binding protein B | 0.330 | ||
| AR | androgen receptor | 0.328 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.327 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.300 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.289 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.280 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.279 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.269 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.267 | Human Rat | |
| IL8 | interleukin 8 | 0.231 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.223 | ||
| DSG2 | desmoglein 2 | 0.216 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.216 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.215 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.210 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.197 | Human | |
| RALB | v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) | 0.196 | ||
| APC | adenomatous polyposis coli | 0.193 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.192 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.189 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.186 | Human | |
| TBXA2R | thromboxane A2 receptor | 0.185 | Human | |
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.182 | Human | |
| ESR1 | estrogen receptor 1 | 0.153 | Rat | |
| RNASE4 | ribonuclease, RNase A family, 4 | 0.147 | Human | |
| TGFB3 | transforming growth factor, beta 3 | 0.142 | ||
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.138 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.133 | ||
| PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.132 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.131 | ||
| APOE | apolipoprotein E | 0.128 | ||
| FGF10 | fibroblast growth factor 10 | 0.128 | ||
| PGF | placental growth factor | 0.124 | Human | |
| NRP1 | neuropilin 1 | 0.122 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.122 | ||
| PELI3 | pellino homolog 3 (Drosophila) | 0.120 | ||
| IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.118 | Rat | |
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.118 | Human | |
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.117 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.117 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.115 | ||
| RUNX1 | runt-related transcription factor 1 | 0.112 | ||
| EDN1 | endothelin 1 | 0.111 | ||
| KITLG | KIT ligand | 0.111 | ||
| IL6R | interleukin 6 receptor | 0.111 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.107 | ||
| DCN | decorin | 0.098 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.097 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.094 | Human | |
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.092 | ||
| IL1B | interleukin 1, beta | 0.091 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.085 | ||
| C3 | complement component 3 | 0.083 | ||
| CREBBP | CREB binding protein | 0.077 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.077 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.076 | ||
| IL2RB | interleukin 2 receptor, beta | 0.075 | ||
| RARA | retinoic acid receptor, alpha | 0.074 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.071 | ||
| A2M | alpha-2-macroglobulin | 0.066 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.065 | ||
| ATF5 | activating transcription factor 5 | 0.064 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.064 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.063 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.059 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.058 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.057 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.057 | ||
| HR | hairless homolog (mouse) | 0.056 | ||
| JAK1 | Janus kinase 1 | 0.055 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.055 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.054 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.054 | ||
| MARCO | macrophage receptor with collagenous structure | 0.053 | ||
| MPO | myeloperoxidase | 0.052 | ||
| FGF7 | fibroblast growth factor 7 | 0.052 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.051 | ||
| TCF4 | transcription factor 4 | 0.051 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.050 | ||
| PRTN3 | proteinase 3 | 0.048 | Human | |
| MEF2C | myocyte enhancer factor 2C | 0.048 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.046 | ||
| MEF2A | myocyte enhancer factor 2A | 0.044 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.044 | ||
| INO80B | INO80 complex subunit B | 0.043 | ||
| IDE | insulin-degrading enzyme | 0.043 | ||
| LDLR | low density lipoprotein receptor | 0.043 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.042 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.042 | Human | |
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.042 | ||
| IL10 | interleukin 10 | 0.042 | ||
| TF | transferrin | 0.041 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.041 | ||
| FGFR1OP2 | FGFR1 oncogene partner 2 | 0.040 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.040 | Human | |
| HSPG2 | heparan sulfate proteoglycan 2 | 0.039 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.038 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.038 | Human | |
| PRMT2 | protein arginine methyltransferase 2 | 0.038 | ||
| KLF6 | Kruppel-like factor 6 | 0.038 | ||
| DARC | Duffy blood group, chemokine receptor | 0.037 | ||
| FBLN1 | fibulin 1 | 0.037 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.036 | ||
| CD34 | CD34 molecule | 0.036 | ||
| IRAK3 | interleukin-1 receptor-associated kinase 3 | 0.036 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.036 | ||
| VEGFC | vascular endothelial growth factor C | 0.036 | Human | |
| COL1A1 | collagen, type I, alpha 1 | 0.035 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.035 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.034 | ||
| SELE | selectin E | 0.033 | ||
| ESRRG | estrogen-related receptor gamma | 0.033 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.033 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.033 | ||
| JUP | junction plakoglobin | 0.033 | Human | |
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.033 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.032 | ||
| SLAMF8 | SLAM family member 8 | 0.032 | ||
| EP300 | E1A binding protein p300 | 0.032 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.031 | Human | |
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.030 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.030 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.030 | Rat | |
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.030 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.029 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.029 | ||
| SLMAP | sarcolemma associated protein | 0.029 | ||
| STRN3 | striatin, calmodulin binding protein 3 | 0.029 | ||
| KLF5 | Kruppel-like factor 5 (intestinal) | 0.029 | ||
| WDYHV1 | WDYHV motif containing 1 | 0.028 | ||
| STC1 | stanniocalcin 1 | 0.028 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.028 | Human | |
| C2 | complement component 2 | 0.027 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.026 | ||
| ORC2 | origin recognition complex, subunit 2 | 0.026 | ||
| SIRT1 | sirtuin 1 | 0.026 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.026 | Human | |
| PRKCA | protein kinase C, alpha | 0.025 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.025 | ||
| PDGFC | platelet derived growth factor C | 0.025 | ||
| PARVB | parvin, beta | 0.025 | ||
| CTBP1 | C-terminal binding protein 1 | 0.025 | ||
| ELANE | elastase, neutrophil expressed | 0.024 | ||
| RHOB | ras homolog gene family, member B | 0.024 | ||
| AZU1 | azurocidin 1 | 0.024 | Human | |
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.023 | ||
| SRGN | serglycin | 0.023 | ||
| PARVA | parvin, alpha | 0.023 | ||
| HP | haptoglobin | 0.023 | ||
| PLAT | plasminogen activator, tissue | 0.023 | ||
| CD163 | CD163 molecule | 0.023 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.023 | ||
| TDGF1 | teratocarcinoma-derived growth factor 1 | 0.022 | ||
| TAX1BP1 | Tax1 (human T-cell leukemia virus type I) binding protein 1 | 0.022 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.022 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.022 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.022 | ||
| JUN | jun proto-oncogene | 0.022 | Rat | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.021 | Rat | |
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.021 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.021 | ||
| SP1 | Sp1 transcription factor | 0.021 | ||
| SLA | Src-like-adaptor | 0.021 | ||
| EEA1 | early endosome antigen 1 | 0.020 | ||
| RABEP1 | rabaptin, RAB GTPase binding effector protein 1 | 0.020 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.020 | ||
| DSP | desmoplakin | 0.020 | ||
| IER3 | immediate early response 3 | 0.020 | ||
| CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | 0.019 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.019 | Human | |
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.019 | ||
| CH25H | cholesterol 25-hydroxylase | 0.019 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.019 | ||
| NOV | nephroblastoma overexpressed gene | 0.019 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.019 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.019 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.018 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.018 | ||
| GPX3 | glutathione peroxidase 3 (plasma) | 0.018 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.018 | ||
| INHBA | inhibin, beta A | 0.018 | ||
| STAB1 | stabilin 1 | 0.018 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.018 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.017 | ||
| CFD | complement factor D (adipsin) | 0.017 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.017 | ||
| BMP2 | bone morphogenetic protein 2 | 0.017 | Human | |
| THBS1 | thrombospondin 1 | 0.017 | ||
| YAP1 | Yes-associated protein 1 | 0.017 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.017 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.017 | ||
| CSNK1E | casein kinase 1, epsilon | 0.017 | ||
| TNF | tumor necrosis factor | 0.017 | ||
| CTSG | cathepsin G | 0.016 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.016 | ||
| GNLY | granulysin | 0.016 | ||
| INSR | insulin receptor | 0.016 | ||
| RNH1 | ribonuclease/angiogenin inhibitor 1 | 0.016 | ||
| G0S2 | G0/G1switch 2 | 0.016 | ||
| FBXW11 | F-box and WD repeat domain containing 11 | 0.016 | ||
| PLG | plasminogen | 0.016 | ||
| LEP | leptin | 0.016 | ||
| CTTNBP2NL | CTTNBP2 N-terminal like | 0.016 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.016 | ||
| CD68 | CD68 molecule | 0.016 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.015 | ||
| FSTL1 | follistatin-like 1 | 0.015 | ||
| TMEM176B | transmembrane protein 176B | 0.015 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.015 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.015 | ||
| CD14 | CD14 molecule | 0.015 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.015 | Human | |
| EMD | emerin | 0.015 | ||
| FOXO1 | forkhead box O1 | 0.014 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.014 | ||
| PXN | paxillin | 0.014 | ||
| TLR4 | toll-like receptor 4 | 0.014 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.014 | Human | |
| VHL | von Hippel-Lindau tumor suppressor | 0.014 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.014 | ||
| MIF4GD | MIF4G domain containing | 0.014 | ||
| FHL2 | four and a half LIM domains 2 | 0.014 | ||
| GHRL | ghrelin/obestatin prepropeptide | 0.013 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.013 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.013 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.013 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.013 | ||
| ENG | endoglin | 0.013 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.013 | ||
| BMP4 | bone morphogenetic protein 4 | 0.013 | ||
| DPT | dermatopontin | 0.013 | ||
| KRT5 | keratin 5 | 0.013 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.013 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.013 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.013 | ||
| C3AR1 | complement component 3a receptor 1 | 0.013 | Rat | |
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.013 | ||
| BTRC | beta-transducin repeat containing | 0.012 | ||
| ITGA6 | integrin, alpha 6 | 0.012 | ||
| EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 0.012 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.012 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.012 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.012 | ||
| ATF3 | activating transcription factor 3 | 0.012 | ||
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.012 | ||
| PDZD3 | PDZ domain containing 3 | 0.012 | ||
| THBD | thrombomodulin | 0.012 | ||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | 0.012 | ||
| PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.012 | ||
| CFH | complement factor H | 0.012 | ||
| S100A9 | S100 calcium binding protein A9 | 0.012 | ||
| FTL | ferritin, light polypeptide | 0.012 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.012 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.012 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.012 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.012 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.012 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.012 | ||
| ADM | adrenomedullin | 0.012 | ||
| MYLK2 | myosin light chain kinase 2 | 0.012 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.012 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.012 | ||
| RUNX3 | runt-related transcription factor 3 | 0.012 | ||
| GGT5 | gamma-glutamyltransferase 5 | 0.011 | ||
| MGP | matrix Gla protein | 0.011 | ||
| OMD | osteomodulin | 0.011 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.011 | Rat | |
| BCL2A1 | BCL2-related protein A1 | 0.011 | ||
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.011 | ||
| HK3 | hexokinase 3 (white cell) | 0.011 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.011 | ||
| PCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) | 0.011 | ||
| TERF2 | telomeric repeat binding factor 2 | 0.011 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.011 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.011 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.011 | Human | |
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.011 | ||
| PTGDS | prostaglandin D2 synthase 21kDa (brain) | 0.011 | ||
| CTSL1 | cathepsin L1 | 0.011 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.011 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.011 | Human | |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.010 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.010 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.010 | ||
| MS4A3 | membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | 0.010 | ||
| CAMP | cathelicidin antimicrobial peptide | 0.010 | ||
| C10orf54 | chromosome 10 open reading frame 54 | 0.010 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.010 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.010 | ||
| MDFI | MyoD family inhibitor | 0.010 | ||
| FN1 | fibronectin 1 | 0.010 |